SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001689813-22-000019
Filing Date
2022-03-11
Accepted
2022-03-11 16:44:23
Documents
6
Period of Report
2022-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2022bhvndef14aproxystatem.htm DEF 14A 768458
2 GRAPHIC bhvn2022proxycardp1.jpg GRAPHIC 1286163
3 GRAPHIC bhvn2979219215221a01.jpg GRAPHIC 84292
4 GRAPHIC bhvnlogo.jpg GRAPHIC 19308
5 GRAPHIC bhvnproxycardp1.jpg GRAPHIC 207228
6 GRAPHIC chart-2bc4ed7105004b3c95f.jpg GRAPHIC 107265
  Complete submission text file 0001689813-22-000019.txt   3116361
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38080 | Film No.: 22733737
SIC: 2834 Pharmaceutical Preparations